Watch: HPV vaccination roll out, climate change, metabolic diseases and more | Health Wrap
In this episode of Health Wrap, senior health journalists Ramya Kannan and Zubeda Hamid discuss the week’s important developments in public health. This episode looks at the rollout of Human papillomavirus (HPV) vaccination across States in India to prevent cervical cancer, which continues to claim thousands of lives each year.
The Health Wrap by The Hindu recently featured an interview with researchers from the Indian Institute of Technology Madras who have developed a new injectable hydrogel to treat fibrosis and other chronic degenerative conditions. Prof. Vignesh Muthuvijayan and Ms. Varshiny Gopinath, both from the Department of Biotechnology at IIT Madras, discussed their innovative approach.
Fibrosis, a condition characterized by the excessive accumulation of fibrous connective tissue, often results from chronic inflammation. It affects various organs, including the liver, lungs, heart, and kidneys, leading to severe health complications. The hydrogel-based treatment developed by the IIT Madras team offers a promising solution for managing fibrosis and related chronic diseases.
The hydrogel is designed to be injectable, allowing for targeted delivery directly to the affected tissues. This targeted approach ensures that the hydrogel can effectively reach the source of the problem, minimizing potential side effects and maximizing therapeutic benefits. The material's unique properties enable it to promote tissue repair and regeneration, making it an ideal candidate for treating fibrosis and other chronic degenerative conditions.
During the interview, Prof. Muthuvijayan and Ms. Gopinath explained the scientific principles behind their hydrogel, highlighting its biocompatibility and biodegradability. These properties are crucial for ensuring that the hydrogel is safe for use in the human body and that it can be gradually absorbed or broken down after completing its therapeutic role.
The researchers emphasized the potential impact of their work on improving the lives of patients suffering from fibrosis. By providing an innovative and targeted treatment option, the hydrogel-based approach has the potential to significantly enhance the quality of life for individuals affected by this challenging condition.
The IIT Madras team's research represents a significant step forward in the field of tissue engineering and biomaterials. As they continue to refine and develop their hydrogel technology, it holds the promise of offering new hope for patients battling fibrosis and other chronic degenerative diseases.
Written by urgent.news from The Hindu Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
